Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition

Background: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids a...

Full description

Bibliographic Details
Main Authors: Crowe, F, Allen, N, Appleby, P, Overvad, K, Aardestrup, I, Johnsen, N, Tjønneland, A, Linseisen, J, Kaaks, R, Boeing, H, Kröger, J, Trichopoulou, A, Zavitsanou, A, Trichopoulos, D, Sacerdote, C, Palli, D, Tumino, R, Agnoli, C, Kiemeney, L, Bueno-de-Mesquita, H, Chirlaque, M, Ardanaz, E, Larrañaga, N, Quirós, JR, Sánchez, M
Format: Journal article
Language:English
Published: 2008
_version_ 1826279686196428800
author Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, M
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
author_facet Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, M
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
author_sort Crowe, F
collection OXFORD
description Background: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. Design: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. Results: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, α-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. Conclusion: The associations between palmitic, stearic, myristic, α-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further. © 2008 American Society for Nutrition.
first_indexed 2024-03-07T00:02:29Z
format Journal article
id oxford-uuid:766ed103-f5c6-4c59-b7b7-ed1698547c01
institution University of Oxford
language English
last_indexed 2024-03-07T00:02:29Z
publishDate 2008
record_format dspace
spelling oxford-uuid:766ed103-f5c6-4c59-b7b7-ed1698547c012022-03-26T20:16:24ZFatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and NutritionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:766ed103-f5c6-4c59-b7b7-ed1698547c01EnglishSymplectic Elements at Oxford2008Crowe, FAllen, NAppleby, POvervad, KAardestrup, IJohnsen, NTjønneland, ALinseisen, JKaaks, RBoeing, HKröger, JTrichopoulou, AZavitsanou, ATrichopoulos, DSacerdote, CPalli, DTumino, RAgnoli, CKiemeney, LBueno-de-Mesquita, HChirlaque, MArdanaz, ELarrañaga, NQuirós, JRSánchez, MBackground: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. Objective: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. Design: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. Results: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, α-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. Conclusion: The associations between palmitic, stearic, myristic, α-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further. © 2008 American Society for Nutrition.
spellingShingle Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, M
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title_full Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title_fullStr Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title_full_unstemmed Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title_short Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition
title_sort fatty acid composition of plasma phospholipids and risk of prostate cancer in a case control analysis nested within the european prospective investigation into cancer and nutrition
work_keys_str_mv AT crowef fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT allenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT applebyp fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT overvadk fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT aardestrupi fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT johnsenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tjønnelanda fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT linseisenj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kaaksr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT boeingh fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT krogerj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopouloua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT zavitsanoua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopoulosd fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT sacerdotec fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT pallid fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tuminor fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT agnolic fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kiemeneyl fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT buenodemesquitah fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT chirlaquem fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT ardanaze fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT larranagan fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT quirosjr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT sanchezm fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition